Japan to put more weigh on generic drug markets.

Published: 2005-05-03 07:00:00

Updated: 2005-05-03 07:00:00

The Japanese drug markets having traditionally prevailed with branded drugs seemed to shift more to generic drugs after improving its business concept and undertaking an M&A of generic drug companies.

The Korea Pharmaceutical Trade Association (KPTA: chairman: Chung Seung-whan) took part in th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK